Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non Squamous Lung Cancer × Therapeutics × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Lung Neoplasms 14 Breast Neoplasms 5 Fatigue 4 Small Cell Lung Carcinoma 3 Melanoma 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Prostatic Neoplasms 2 Pain 2 Ovarian Neoplasms 2 Neoplasms 2 Lymphoma 2 Vomiting 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Pleural Effusion, Malignant 1 Non Squamous Lung Cancer 1 Non Small Cell Lung Caner 1 Neoplasm Metastasis 1 Nausea 1 Liposarcoma 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Health Education 1 Head and Neck Neoplasms 1 Extensive Stage Small Cell Lung Carcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01154140 2017-11-06

PROFILE 1014

Pfizer

Phase 3 Completed

343 enrolled 31 charts

Non Squamous Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡